World Wires · story 29395 · unverified · 1 source(s)

Newron Provides Update on FDA Clinical Hold and Phase 3 ENIGMA-TRS Development Program

Management call today at 3.30 pm CEST

Open in the desk

Coverage

• Newron Provides Update on FDA Clinical Hold and Phase 3 ENIGMA-TRS Development Program GlobeNewswire: public companies · tier D · clear net · 2026-10-08 11:00 UTC

What this site indexes